The Filing Desk

Trulieve Cannabis vs USANA Health Sciences

Trulieve Cannabis TRLV · USANA Health Sciences USNA · Personal Care Products

Trulieve Cannabis reported revenue of $1.2 billion in fiscal 2025, 1.3 times USANA Health Sciences' $925 million in fiscal 2025. Trulieve Cannabis' revenue fell 0.5% in its latest year, and USANA Health Sciences' grew 8.3%. Trulieve Cannabis had an operating margin of 12.2%, against 4.0% at USANA Health Sciences. Free cash flow was $229 million at Trulieve Cannabis and $9 million at USANA Health Sciences. Their fiscal years end in different months (December 31 and January 3), so the periods don't line up exactly.

Side by side

Trulieve CannabisUSANA Health Sciences
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Jan 3, 2026
Revenue$1.2B$925M
Revenue growth−0.5%8.3%
Revenue growth a year, last 5 years17.8%−4.0%
Gross margin60.2%78.3%
Operating margin12.2%4.0%
Net margin−10.3%1.2%
Free cash flow$229M$9M
Free cash flow margin19.4%0.9%
Return on capital5.8%—
Net debt to EBITDA−0.2x—
Dividends and buybacks$0M$28M
Change in diluted share count0.7%−3.1%
Last close$9.35$13.16
P/E at the last close——
Insider trades, last 12 monthssold $14.7 millionsold $894,829
Piotroski F-score5 of 9—
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Trulieve CannabisUSANA Health Sciences
Operating margin
Percent of revenue
Trulieve CannabisUSANA Health Sciences
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Trulieve CannabisUSANA Health Sciences

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Trulieve Cannabis and USANA Health Sciences pages.